Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9Z1N6

Entry ID Method Resolution Chain Position Source
AF-Q9Z1N6-F1 Predicted AlphaFoldDB

22 variants for Q9Z1N6

Variant ID(s) Position Change Description Diseaes Association Provenance
rs39959128 3 R>G No EVA
rs1131733500 14 R>H No EVA
rs3389273759 25 E>G No EVA
rs3389269531 31 M>K No EVA
rs3403853561 33 R>M No EVA
rs3403953973 37 W>G No EVA
rs3389279597 59 E>G No EVA
rs3389279572 79 A>V No EVA
rs3389271238 85 C>F No EVA
rs3389244700 87 L>M No EVA
rs3389264050 104 A>V No EVA
rs3389273909 189 T>A No EVA
rs3389202046 195 Y>F No EVA
rs3389264022 229 P>A No EVA
rs3403925801 245 C>* No EVA
rs3389282782 247 H>R No EVA
rs3389256361 249 L>M No EVA
rs3389269521 270 N>K No EVA
rs3389239603 287 W>L No EVA
rs3389286842 294 Q>K No EVA
rs37000063 323 P>L No EVA
rs3389256389 324 P>S No EVA

No associated diseases with Q9Z1N6

4 regional properties for Q9Z1N6

Type Name Position InterPro Accession
domain Netrin domain 172 - 295 IPR001134
domain Netrin module, non-TIMP type 186 - 289 IPR018933
domain Frizzled domain 35 - 157 IPR020067
domain SFRP2, cysteine-rich domain 36 - 163 IPR041764

Functions

Description
EC Number
Subcellular Localization
  • Secreted
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cell surface The external part of the cell wall and/or plasma membrane.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

1 GO annotations of molecular function

Name Definition
Wnt-protein binding Binding to a Wnt-protein, a secreted growth factor involved in signaling.

17 GO annotations of biological process

Name Definition
bone morphogenesis The process in which bones are generated and organized.
canonical Wnt signaling pathway The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
cell differentiation The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
negative regulation of canonical Wnt signaling pathway Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
negative regulation of cell population proliferation Any process that stops, prevents or reduces the rate or extent of cell proliferation.
negative regulation of DNA-binding transcription factor activity Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
negative regulation of JNK cascade Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the JNK cascade.
negative regulation of non-canonical Wnt signaling pathway Any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway.
negative regulation of sodium-dependent phosphate transport Any process that stops, prevents, or reduces the frequency, rate or extent of sodium-dependent phosphate transport.
phosphate ion homeostasis Any process involved in the maintenance of an internal steady state of phosphate ions within an organism or cell.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
positive regulation of canonical Wnt signaling pathway Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
positive regulation of epidermal cell differentiation Any process that activates or increases the frequency, rate or extent of epidermal cell differentiation.
positive regulation of gene expression Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
positive regulation of keratinocyte apoptotic process Any process that activates or increases the frequency, rate or extent of keratinocyte apoptotic process.
positive regulation of receptor internalization Any process that activates or increases the frequency, rate or extent of receptor internalization.
regulation of BMP signaling pathway Any process that modulates the frequency, rate or extent of the activity of any BMP receptor signaling pathway.

23 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O19116 SFRP1 Secreted frizzled-related protein 1 Bos taurus (Bovine) PR
Q9DEQ4 SFRP1 Secreted frizzled-related protein 1 Gallus gallus (Chicken) PR
O57328 FZD1 Frizzled-1 Gallus gallus (Chicken) PR
Q9IA96 SFRP2 Secreted frizzled-related protein 2 Gallus gallus (Chicken) PR
Q8N474 SFRP1 Secreted frizzled-related protein 1 Homo sapiens (Human) PR
Q9ULW2 FZD10 Frizzled-10 Homo sapiens (Human) PR
Q96HF1 SFRP2 Secreted frizzled-related protein 2 Homo sapiens (Human) PR
O75084 FZD7 Frizzled-7 Homo sapiens (Human) PR
Q9UP38 FZD1 Frizzled-1 Homo sapiens (Human) PR
Q14332 FZD2 Frizzled-2 Homo sapiens (Human) PR
O00144 FZD9 Frizzled-9 Homo sapiens (Human) PR
O60353 FZD6 Frizzled-6 Homo sapiens (Human) PR
Q6FHJ7 SFRP4 Secreted frizzled-related protein 4 Homo sapiens (Human) PR
O70421 Fzd1 Frizzled-1 Mus musculus (Mouse) PR
P97299 Sfrp2 Secreted frizzled-related protein 2 Mus musculus (Mouse) PR
Q61090 Fzd7 Frizzled-7 Mus musculus (Mouse) PR
Q8C4U3 Sfrp1 Secreted frizzled-related protein 1 Mus musculus (Mouse) PR
Q9JIP6 Fzd2 Frizzled-2 Mus musculus (Mouse) PR
Q08463 Fzd1 Frizzled-1 Rattus norvegicus (Rat) PR
Q08464 Fzd2 Frizzled-2 Rattus norvegicus (Rat) PR
Q9JLS4 Sfrp4 Secreted frizzled-related protein 4 Rattus norvegicus (Rat) PR
Q7YRN1 SFRP4 Secreted frizzled-related protein 4 Macaca mulatta (Rhesus macaque) PR
Q5BL72 fzd7 Frizzled-7 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MLRSILVALC LWLRLALGVR GAPCEAVRIP MCRHMPWNIT RMPNHLHHST QENAILAIEQ
70 80 90 100 110 120
YEELVDVNCS SVLRFFLCAM YAPICTLEFL HDPIKPCKSV CQRARDDCEP LMKMYNHSWP
130 140 150 160 170 180
ESLACDELPV YDRGVCISPE AIVTDLPEDV KWIDITPDMM VQERSFDADC KRLSPDRCKC
190 200 210 220 230 240
KKVKPTLATY LSKNYSYVIH AKIKAVQRSG CNEVTTVVDV KEIFKSLSPI PRTQVPLITN
250 260 270 280 290 300
SSCQCPHILP HQDVLIMCYE WRSRMMLLEN CLVEKWRDQL SRRSIQWEER LQEQQRTIQD
310 320 330 340 350
KKQIASRTSR TSRSNPPKSK GRPPAPKPAS PKKNIKARSA PKKSNLKKSA S